Dashboard
Manage Tickers

LOVELovesac Co

Nasdaq lovesac.com


$ 24.26 $ -2.01 (-7.65 %)    

Friday, 14-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 24.25
$ 25.50
$ 0.00 x 0
$ 0.00 x 0
$ 23.67 - $ 25.67
$ 14.18 - $ 29.81
459,872
na
376.79M
$ 1.92
$ 25.09
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-13-2024 05-05-2024 10-Q
2 04-11-2024 02-04-2024 10-K
3 12-06-2023 10-29-2023 10-Q
4 11-03-2023 07-30-2023 10-Q
5 06-09-2023 04-30-2023 10-Q
6 03-29-2023 01-29-2023 10-K
7 12-08-2022 10-30-2022 10-Q
8 09-09-2022 07-31-2022 10-Q
9 06-08-2022 05-01-2022 10-Q
10 03-30-2022 01-30-2022 10-K
11 12-09-2021 10-31-2021 10-Q
12 09-09-2021 08-01-2021 10-Q
13 06-11-2021 05-02-2021 10-Q
14 04-14-2021 01-31-2021 10-K
15 12-09-2020 11-01-2020 10-Q
16 09-10-2020 08-02-2020 10-Q
17 06-09-2020 05-03-2020 10-Q
18 04-29-2020 02-02-2020 10-K
19 12-18-2019 11-03-2019 10-Q
20 09-13-2019 08-04-2019 10-Q
21 06-18-2019 05-05-2019 10-Q
22 05-03-2019 02-03-2019 10-K
23 12-19-2018 11-04-2018 10-Q
24 09-14-2018 08-05-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

roth-mkm-maintains-buy-on-lovesac-maintains-30-price-target
Roth MKM Maintains Buy on Lovesac, Maintai...
06/14/2024 15:30:23

Roth MKM analyst Matt Koranda maintains Lovesac (NASDAQ:LOVE) with a Buy and maintains $30 price target.

da-davidson-maintains-buy-on-lovesac-raises-price-target-to-32
DA Davidson Maintains Buy on Lovesac, Rais...
06/14/2024 14:51:24

DA Davidson analyst Tom Forte maintains Lovesac (NASDAQ:LOVE) with a Buy and raises the price target from $24 to $32.

canaccord-genuity-maintains-buy-on-lovesac-maintains-36-price-target
Canaccord Genuity Maintains Buy on Lovesac...
06/14/2024 13:37:32

Canaccord Genuity analyst Maria Ripps maintains Lovesac (NASDAQ:LOVE) with a Buy and maintains $36 price target.

12-consumer-discretionary-stocks-moving-in-thursdays-after-market-session
12 Consumer Discretionary Stocks Moving In...
06/13/2024 20:31:08

whats-going-on-with-home-furnishing-brand-lovesac-shares-after-q1-earnings
What's Going On With Home Furnishing Brand...
06/13/2024 14:35:35

Lovesac (NASDAQ: LOVE) shares rise after reporting Q1 results, with narrower-than-expected loss and strong sales performance.

lovesac-sees-q2-net-sales-of-152m-160m-vs-15618m-estimate-projects-basic-loss-per-share-of-037-053-vs-007-estimate
Lovesac Sees Q2 Net Sales Of $152M-$160M V...
06/13/2024 11:11:35

The Company currently expects the following for the second quarter of fiscal 2025: Net sales in the range of $152 million to...

lovesac-reaffirms-fiscal-2025-outlook-sees-net-sales-of-700m-770m-vs-71453m-estimate-projects-diluted-eps-of-106-159-vs-123-estimate
Lovesac Reaffirms Fiscal 2025 Outlook: See...
06/13/2024 11:08:18

The Company expects the following for the full year of fiscal 2025: Net sales in the range of $700 million to $770 million. ...

lovesac-q1-eps-083-beats-096-estimate-sales-13264m-beat-12807m-estimate
Lovesac Q1 EPS $(0.83) Beats $(0.96) Estim...
06/13/2024 11:03:39

Lovesac (NASDAQ:LOVE) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(0.96) by 13...

top-wall-street-forecasters-revamp-lovesac-expectations-ahead-of-q1-earnings
Top Wall Street Forecasters Revamp Lovesac...
06/13/2024 06:41:11

peeling-back-the-layers-exploring-lovesac-through-analyst-insights
Peeling Back The Layers: Exploring Lovesac...
06/11/2024 15:00:47

roth-mkm-reiterates-buy-on-lovesac-maintains-30-price-target
Roth MKM Reiterates Buy on Lovesac, Mainta...
06/11/2024 14:16:16

Roth MKM analyst Matt Koranda reiterates Lovesac (NASDAQ:LOVE) with a Buy and maintains $30 price target.

cannara-biotech-reports-51-yoy-revenue-increase-in-q2-wider-net-loss
Cannara Biotech Reports 51% YoY Revenue In...
05/01/2024 19:45:45

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-m...

oppenheimer-maintains-outperform-on-lovesac-lowers-price-target-to-35
Oppenheimer Maintains Outperform on Lovesa...
05/01/2024 12:21:14

Oppenheimer analyst Brian Nagel maintains Lovesac (NASDAQ:LOVE) with a Outperform and lowers the price target from $60 to $35.

over-1m-bet-on-citi-trends-check-out-these-3-stocks-insiders-are-buying
Over $1M Bet On Citi Trends? Check Out The...
04/24/2024 14:03:19

insiders-buying-lovesac-company-and-3-other-stocks
Insiders Buying Lovesac Company And 3 Othe...
04/19/2024 11:29:02

expert-ratings-for-lovesac
Expert Ratings For Lovesac
04/17/2024 16:00:20

maxim-group-initiates-coverage-on-lovesac-with-buy-rating-announces-price-target-of-36
Maxim Group Initiates Coverage On Lovesac ...
04/17/2024 15:08:16

Maxim Group analyst Tom Forte initiates coverage on Lovesac (NASDAQ:LOVE) with a Buy rating and announces Price Target of $36.

why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session
Why JPMorgan Shares Are Trading Lower By A...
04/12/2024 18:47:23

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

canaccord-genuity-maintains-buy-on-lovesac-lowers-price-target-to-36
Canaccord Genuity Maintains Buy on Lovesac...
04/12/2024 15:49:08

Canaccord Genuity analyst Maria Ripps maintains Lovesac (NASDAQ:LOVE) with a Buy and lowers the price target from $44 to $36.

roth-mkm-maintains-buy-on-lovesac-lowers-price-target-to-30
Roth MKM Maintains Buy on Lovesac, Lowers ...
04/12/2024 12:20:22

Roth MKM analyst Matt Koranda maintains Lovesac (NASDAQ:LOVE) with a Buy and lowers the price target from $34 to $30.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)